Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9361744rdf:typepubmed:Citationlld:pubmed
pubmed-article:9361744lifeskim:mentionsumls-concept:C0041234lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0005918lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0041221lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0205146lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:9361744lifeskim:mentionsumls-concept:C0243130lld:lifeskim
pubmed-article:9361744pubmed:issue4lld:pubmed
pubmed-article:9361744pubmed:dateCreated1998-2-19lld:pubmed
pubmed-article:9361744pubmed:abstractTextA field study of the immune response to the shed acute phase antigen (SAPA) of Trypanosoma cruzi was carried out in the locality of Mizque, Cochabamba department, Bolivia. Schoolchildren (266), with an average of 8.6 +/- 3.6 years, were surveyed for parasitological and serological diagnosis, as well as antibodies directed against SAPA using the corresponding recombinant protein in ELISA. The antibodies against SAPA were shown in 82% of patients presenting positive serological diagnosis (IgG specific antibodies). The positive and negative predictive values were 0.88. Antibodies anti-SAPA were shown in 80.8% of the chagasic patients in the initial stage of the infection (positive IgM serology and/or positive buffy coat (BC) test) and in 81.4% of the patients in the indeterminate stage of the infection (positive IgG serology with negative BC and IgM tests). These results show that the anti-SAPA response is not only present during the initial stage of the infection (few months) but extends some years after infection.lld:pubmed
pubmed-article:9361744pubmed:languageenglld:pubmed
pubmed-article:9361744pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9361744pubmed:citationSubsetIMlld:pubmed
pubmed-article:9361744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9361744pubmed:statusMEDLINElld:pubmed
pubmed-article:9361744pubmed:issn0074-0276lld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:SanchezDDlld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:BossenoM FMFlld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:BrenièreS FSFlld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:NoireauFFlld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:WinckerPPlld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:YaksicNNlld:pubmed
pubmed-article:9361744pubmed:authorpubmed-author:TelleriaJJlld:pubmed
pubmed-article:9361744pubmed:issnTypePrintlld:pubmed
pubmed-article:9361744pubmed:volume92lld:pubmed
pubmed-article:9361744pubmed:ownerNLMlld:pubmed
pubmed-article:9361744pubmed:authorsCompleteYlld:pubmed
pubmed-article:9361744pubmed:pagination503-7lld:pubmed
pubmed-article:9361744pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:meshHeadingpubmed-meshheading:9361744-...lld:pubmed
pubmed-article:9361744pubmed:articleTitleImmune response to Trypanosoma cruzi shed acute phase antigen in children from an endemic area for Chagas' disease in Bolivia.lld:pubmed
pubmed-article:9361744pubmed:affiliationUMR ORSTOM/CNRS n(o) 9926: Génétique Moléculaire des Parasites et des Vecteurs, La Paz, Bolivia.lld:pubmed
pubmed-article:9361744pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9361744pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9361744lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9361744lld:pubmed